Quantcast
Channel: cafepharma - GS-7977
Browsing latest articles
Browse All 20 View Live
↧

Gilead Suffers First Hep C Drug Setback

Gilead Suffers First Hep C Drug Setback TheStreet.com

View Article


Achillion, Vertex rally on Gilead's woes

Achillion, Vertex rally on Gilead's woes Marketwatch

View Article


1 Biotech Punished by Hep-C Overreaction

1 Biotech Punished by Hep-C Overreaction Motley Fool

View Article

Bristol-Gilead Hep C Drug Data Leaks

Bristol-Gilead Hep C Drug Data Leaks TheStreet.com

View Article

Gilead Bets on Hepatitis C Data to Back Pharmasset Deal

Gilead Bets on Hepatitis C Data to Back Pharmasset Deal Bloomberg

View Article


Gilead Sciences' Hepatitis Drug in Spotlight at Major Medical Meeting

Gilead Sciences' Hepatitis Drug in Spotlight at Major Medical Meeting Minyanville

View Article

Gilead Rises After Hepatitis Data Open New Test Options

Gilead Rises After Hepatitis Data Open New Test Options Bloomberg

View Article

Partner Up or Get Passed Up

Partner Up or Get Passed Up Motley Fool

View Article


Celebrate the Hep C Wins, for Now

Celebrate the Hep C Wins, for Now Motley Fool

View Article


Gilead, Bristol Shine at EASL Conference

Gilead, Bristol Shine at EASL Conference Motley Fool

View Article

Gilead's Hepatitis C Drug Poised To Reach The Market As One Of The First 'All...

Gilead's Hepatitis C Drug Poised To Reach The Market As One Of The First 'All Oral' Combinations Seeking Alpha

View Article

Bristol CEO says Gilead holding out on hep C tie-up

Bristol CEO says Gilead holding out on hep C tie-up Fierce Biotech

View Article

Gilead Begins Single Pill Hepatitis C Study For 2014 Approval

Gilead Begins Single Pill Hepatitis C Study For 2014 Approval Bloomberg

View Article


Forget the Numbers, This Pipeline Is King

Forget the Numbers, This Pipeline Is King Motley Fool

View Article

Guilt by Association = 30% Slaughter?

Guilt by Association = 30% Slaughter? Motley Fool

View Article


Gilead Sciences Makes Headlines With HIV Prevention Pill, Looks to Hepatitis...

Gilead Sciences Makes Headlines With HIV Prevention Pill, Looks to Hepatitis Drugs for Future Minyanville

View Article

Blockbuster buzz: 15 top therapies in late-stage development

Blockbuster buzz: 15 top therapies in late-stage development Fierce Biotech

View Article


5 Things to Watch This Week in the Health-Care Sector

5 Things to Watch This Week in the Health-Care Sector Motley Fool

View Article

Gilead Climbs on Study Results of Hepatitis C Combo

Gilead Climbs on Study Results of Hepatitis C Combo Bloomberg

View Article

Gilead Shares Hit All-Time High On Positive Trial For Hep C Drug

Gilead Shares Hit All-Time High On Positive Trial For Hep C Drug Yahoo/Investors Business Daily

View Article
Browsing latest articles
Browse All 20 View Live